HF-pEF is associated with left ventricular diastolic dysfunction and concentric left ventricular hypertrophy and has significant mortality and morbidity. The heterogeneity of the disease has resulted in the failure of any drugs for the treatment of HF-pEF. Here are the latest discoveries pertaining to this disease.

September 21, 2021

Case 294: Catastrophic Antiphospholipid Syndrome.

Marianne GolseMarie-Pierre Revel
September 21, 2021

Investigation of the Effects of Cardiovascular Therapeutic Ultrasound Applied in Female and Male Rats' Hearts of Different Ages.

IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
Olivia C CoiadoWillian D O'Brien
September 20, 2021

Supplementary role of left ventricular global longitudinal strain for predicting sudden cardiac death in hypertrophic cardiomyopathy.

European Heart Journal Cardiovascular Imaging
Hyun-Jung LeeYong-Jin Kim
September 20, 2021

Obesity modifies the energetic phenotype of dilated cardiomyopathy.

European Heart Journal
Jennifer J RaynerOliver J Rider
September 20, 2021

Transesophageal Echocardiography Performed by Intensivist and Emergency Physicians-A 5-Year, Single-Center Experience.

Journal of Intensive Care Medicine
Trenton C WrayJonathan Marinaro
September 20, 2021
Open Access

Early Onset Lyme Myopericarditis With Left Ventricular Dysfunction and Mitral Regurgitation.

Journal of Investigative Medicine High Impact Case Reports
Muhammad B MalikSuman Rao
September 20, 2021

Males with abdominal aortic aneurysm have reduced left ventricular systolic and diastolic function.

Clinical Physiology and Functional Imaging
Ida Åström MalmPeter Blomstrand
September 20, 2021

NH2-Terminal Cleavage of Cardiac Troponin I Signals Adaptive Response to Cardiac Stressors.

Journal of Cellular Signaling
Chad M WarrenR John Solaro
September 20, 2021

Novel 4DCT Method to Measure Regional Left Ventricular Endocardial Shortening Before and After Transcatheter Mitral Valve Implantation.

Structural Heart : the Journal of the Heart Team
Gabrielle M ColvertElliot R McVeigh
September 20, 2021

The genetics of cardiac failure: Role of a G protein-coupled receptor polymorphism in therapeutic response in an Indian population.

Journal of Clinical and Translational Research
Sudha RamalingamRamalingam Sankaran
September 20, 2021
Open Access

Optimizing Outcomes in Cardiac Rehabilitation: The Importance of Exercise Intensity.

Frontiers in Cardiovascular Medicine
Jenna L TaylorThomas P Olson
September 20, 2021
Open Access

The Utility of Advanced Cardiovascular Imaging in Cancer Patients-When, Why, How, and the Latest Developments.

Frontiers in Cardiovascular Medicine
Christopher YuKazuaki Negishi
September 20, 2021
Open Access

DeepStrain: A Deep Learning Workflow for the Automated Characterization of Cardiac Mechanics.

Frontiers in Cardiovascular Medicine
Manuel A MoralesCiprian Catana
September 20, 2021
Open Access

Left Atrioventricular Coupling Index to Predict Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis.

Frontiers in Cardiovascular Medicine
Theo PezelJoão A C Lima

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved